BIOSYENT INC. - stock earnings
RX.V Upcoming estimated earnings
| Date | Actual / Estimated EPS | Low Revenue | Actual / Estimated Revenue | High Revenue |
|---|---|---|---|---|
| May 15, 2024 BeforeMarket | - / - | - | - / 8.3 million | - |
RX.V Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q4 | 1.5 million CAD | 8.3 million CAD |
| 2023Q3 | 2.4 million CAD | 8.9 million CAD |
| 2023Q2 | 1.5 million CAD | 8.0 million CAD |
| 2023Q1 | 1.2 million CAD | 6.5 million CAD |
| 2022Q4 | 1.2 million CAD | 7.5 million CAD |
| 2022Q3 | 1.5 million CAD | 6.8 million CAD |
| 2022Q2 | 1.2 million CAD | 6.6 million CAD |
| 2022Q1 | 1.6 million CAD | 7.0 million CAD |
| 2021Q4 | 1.9 million CAD | 7.2 million CAD |
| 2021Q3 | 1.7 million CAD | 6.7 million CAD |
| 2021Q2 | 1.0 million CAD | 7.3 million CAD |
| 2021Q1 | 1.7 million CAD | 7.4 million CAD |
| 2020Q4 | 665702 CAD | 5.7 million CAD |
| 2020Q3 | 955909 CAD | 5.8 million CAD |
| 2020Q2 | 722206 CAD | 4.8 million CAD |
| 2020Q1 | 1.5 million CAD | 6.1 million CAD |
| 2019Q4 | 1.2 million CAD | 5.6 million CAD |
| 2019Q3 | 1.5 million CAD | 6.2 million CAD |
| 2019Q2 | 690843 CAD | 5.2 million CAD |
| 2019Q1 | 978181 CAD | 4.5 million CAD |
| 2018Q4 | 1.7 million CAD | 5.9 million CAD |
| 2018Q3 | 1.3 million CAD | 5.3 million CAD |
| 2018Q2 | 1.6 million CAD | 5.9 million CAD |
| 2018Q1 | 1.1 million CAD | 4.4 million CAD |
| 2017Q4 | 1.5 million CAD | 5.9 million CAD |
| 2017Q3 | 1.3 million CAD | 5.4 million CAD |
| 2017Q2 | 1.6 million CAD | 5.6 million CAD |
| 2017Q1 | 901556 CAD | 3.8 million CAD |
| 2016Q4 | 1.1 million CAD | 5.0 million CAD |
RX.V Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | 6.5 million CAD | 31.6 million CAD |
| 2022 | 5.5 million CAD | 27.9 million CAD |
| 2021 | 6.3 million CAD | 28.6 million CAD |
| 2020 | 3.8 million CAD | 22.3 million CAD |
| 2019 | 4.4 million CAD | 21.4 million CAD |
| 2018 | 5.7 million CAD | 21.5 million CAD |
| 2017 | 5.2 million CAD | 20.8 million CAD |
| 2016 | 4.3 million CAD | 17.9 million CAD |
| 2015 | 3.8 million CAD | 15.4 million CAD |
| 2014 | 3.2 million CAD | 12.2 million CAD |
| 2013 | 1.9 million CAD | 7.8 million CAD |
RX.V
Price: CA$8.24
Dividend Yield: 0.02%
Forward Dividend Yield: 2.15%
Payout Ratio: 33.96%
Dividend Per Share: 0.18 CAD
Earnings Per Share: 0.53 CAD
P/E Ratio: 16.71
Exchange: VAN
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Market Capitalization: 98.6 million
Average Dividend Frequency: 4
Years Paying Dividends: 3